Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials

Background: Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis Vol. 18; no. 9; pp. 1320 - 1325
Main Authors: Benedict, Ralph HB, Smerbeck, Audrey, Parikh, Rajavi, Rodgers, Jonathan, Cadavid, Diego, Erlanger, David
Format: Journal Article
Language:English
Published: London, England SAGE Publications 01.09.2012
Sage Publications
Sage Publications Ltd
Subjects:
ISSN:1352-4585, 1477-0970, 1477-0970
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background: Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain magnetic resonance imaging (MRI) and vocational disability. Unfortunately, there are no validated alternate SDMT forms, which are needed to mitigate practice effects. Objective: The aim of the study was to assess the reliability and equivalence of SDMT alternate forms. Methods: Twenty-five healthy participants completed each of five alternate versions of the SDMT – the standard form, two versions from the Rao Brief Repeatable Battery, and two forms specifically designed for this study. Order effects were controlled using a Latin-square research design. Results: All five versions of the SDMT produced mean values within 3 raw score points of one another. Three forms were very consistent, and not different by conservative statistical tests. The SDMT test–retest reliability using these forms was good to excellent, with all r values exceeding 0.80. Conclusions: For the first time, we find good evidence that at least three alternate versions of the SDMT are of equivalent difficulty in healthy adults. The forms are reliable, and can be implemented in clinical trials emphasizing cognitive outcomes.
AbstractList Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain magnetic resonance imaging (MRI) and vocational disability. Unfortunately, there are no validated alternate SDMT forms, which are needed to mitigate practice effects. The aim of the study was to assess the reliability and equivalence of SDMT alternate forms. Twenty-five healthy participants completed each of five alternate versions of the SDMT - the standard form, two versions from the Rao Brief Repeatable Battery, and two forms specifically designed for this study. Order effects were controlled using a Latin-square research design. All five versions of the SDMT produced mean values within 3 raw score points of one another. Three forms were very consistent, and not different by conservative statistical tests. The SDMT test-retest reliability using these forms was good to excellent, with all r values exceeding 0.80. For the first time, we find good evidence that at least three alternate versions of the SDMT are of equivalent difficulty in healthy adults. The forms are reliable, and can be implemented in clinical trials emphasizing cognitive outcomes.
Background: Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain magnetic resonance imaging (MRI) and vocational disability. Unfortunately, there are no validated alternate SDMT forms, which are needed to mitigate practice effects. Objective: The aim of the study was to assess the reliability and equivalence of SDMT alternate forms. Methods: Twenty-five healthy participants completed each of five alternate versions of the SDMT – the standard form, two versions from the Rao Brief Repeatable Battery, and two forms specifically designed for this study. Order effects were controlled using a Latin-square research design. Results: All five versions of the SDMT produced mean values within 3 raw score points of one another. Three forms were very consistent, and not different by conservative statistical tests. The SDMT test–retest reliability using these forms was good to excellent, with all r values exceeding 0.80. Conclusions: For the first time, we find good evidence that at least three alternate versions of the SDMT are of equivalent difficulty in healthy adults. The forms are reliable, and can be implemented in clinical trials emphasizing cognitive outcomes.
Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain magnetic resonance imaging (MRI) and vocational disability. Unfortunately, there are no validated alternate SDMT forms, which are needed to mitigate practice effects. The aim of the study was to assess the reliability and equivalence of SDMT alternate forms. Twenty-five healthy participants completed each of five alternate versions of the SDMT - the standard form, two versions from the Rao Brief Repeatable Battery, and two forms specifically designed for this study. Order effects were controlled using a Latin-square research design. All five versions of the SDMT produced mean values within 3 raw score points of one another. Three forms were very consistent, and not different by conservative statistical tests. The SDMT test-retest reliability using these forms was good to excellent, with all r values exceeding 0.80. For the first time, we find good evidence that at least three alternate versions of the SDMT are of equivalent difficulty in healthy adults. The forms are reliable, and can be implemented in clinical trials emphasizing cognitive outcomes.
Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain magnetic resonance imaging (MRI) and vocational disability. Unfortunately, there are no validated alternate SDMT forms, which are needed to mitigate practice effects.BACKGROUNDCognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a particularly promising tool due to its sensitivity and robust correlation with brain magnetic resonance imaging (MRI) and vocational disability. Unfortunately, there are no validated alternate SDMT forms, which are needed to mitigate practice effects.The aim of the study was to assess the reliability and equivalence of SDMT alternate forms.OBJECTIVEThe aim of the study was to assess the reliability and equivalence of SDMT alternate forms.Twenty-five healthy participants completed each of five alternate versions of the SDMT - the standard form, two versions from the Rao Brief Repeatable Battery, and two forms specifically designed for this study. Order effects were controlled using a Latin-square research design.METHODSTwenty-five healthy participants completed each of five alternate versions of the SDMT - the standard form, two versions from the Rao Brief Repeatable Battery, and two forms specifically designed for this study. Order effects were controlled using a Latin-square research design.All five versions of the SDMT produced mean values within 3 raw score points of one another. Three forms were very consistent, and not different by conservative statistical tests. The SDMT test-retest reliability using these forms was good to excellent, with all r values exceeding 0.80.RESULTSAll five versions of the SDMT produced mean values within 3 raw score points of one another. Three forms were very consistent, and not different by conservative statistical tests. The SDMT test-retest reliability using these forms was good to excellent, with all r values exceeding 0.80.For the first time, we find good evidence that at least three alternate versions of the SDMT are of equivalent difficulty in healthy adults. The forms are reliable, and can be implemented in clinical trials emphasizing cognitive outcomes.CONCLUSIONSFor the first time, we find good evidence that at least three alternate versions of the SDMT are of equivalent difficulty in healthy adults. The forms are reliable, and can be implemented in clinical trials emphasizing cognitive outcomes.
Author Benedict, Ralph HB
Cadavid, Diego
Erlanger, David
Rodgers, Jonathan
Smerbeck, Audrey
Parikh, Rajavi
Author_xml – sequence: 1
  givenname: Ralph HB
  surname: Benedict
  fullname: Benedict, Ralph HB
  email: benedict@buffalo.edu
– sequence: 2
  givenname: Audrey
  surname: Smerbeck
  fullname: Smerbeck, Audrey
– sequence: 3
  givenname: Rajavi
  surname: Parikh
  fullname: Parikh, Rajavi
– sequence: 4
  givenname: Jonathan
  surname: Rodgers
  fullname: Rodgers, Jonathan
– sequence: 5
  givenname: Diego
  surname: Cadavid
  fullname: Cadavid, Diego
– sequence: 6
  givenname: David
  surname: Erlanger
  fullname: Erlanger, David
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26359887$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22277740$$D View this record in MEDLINE/PubMed
BookMark eNp9kUuLFDEQx4OsuA-9e5KACF5ak-48erwt6xNWBF3PTR7Vay3pzmySFuYb-LHN7MyiDOglVVC_f1XqX6fkaI4zEPKUs1eca_2ad7IVspeci05qrh-QEy60bthKs6Oa13KzrR-T05xvGGNad_IROW7bVmst2An59RUCGosBy4aa2VO4XfCnCTA7oHGkJhRIsylAx5imvH1p-QH022ayMdC3eI2Ffo7e1AYImV5BLm8oTuuAzhSM804yLaHgOgDNLkCKGTN1AefKBFoSmpAfk4djDfBkH8_I9_fvri4-NpdfPny6OL9snFC8NNJb1VrWW6_BeejuUlVXUcIry3xvBACwlVdCuNZ3RoxSWbCGi9b6duzOyMtd33WKt0v97TBhdhCCmSEueeCs00pKprqKPj9Ab-JSzQhbqmd1aK9UpZ7tqcVO4Id1wsmkzXDvcQVe7AGT675jMrPD_IdTnVz1va6c2nGuGpQTjIPDcudhSQZDnTlsjz4cHr0K2YHwvvd_JM1Oks01_L3WP_jf_gq7xA
CitedBy_id crossref_primary_10_1016_j_msard_2022_104375
crossref_primary_10_1016_j_gaitpost_2016_10_016
crossref_primary_10_1016_j_jns_2017_08_019
crossref_primary_10_1093_arclin_acaa028
crossref_primary_10_1212_WNL_0000000000011275
crossref_primary_10_1016_j_rehab_2018_01_006
crossref_primary_10_1007_s10067_019_04468_7
crossref_primary_10_1177_1352458518808204
crossref_primary_10_1016_j_msard_2021_103405
crossref_primary_10_1177_1352458520930371
crossref_primary_10_1016_j_nicl_2019_101716
crossref_primary_10_1016_j_msard_2015_03_004
crossref_primary_10_1080_13854046_2013_871337
crossref_primary_10_1136_jnnp_2024_333994
crossref_primary_10_1007_s11682_020_00264_z
crossref_primary_10_1016_j_autrev_2020_102512
crossref_primary_10_1016_j_msard_2025_106310
crossref_primary_10_1177_1352458519891984
crossref_primary_10_1016_j_msard_2020_102154
crossref_primary_10_1212_WNL_0000000000002883
crossref_primary_10_1080_13854046_2015_1093173
crossref_primary_10_1177_1352458517690821
crossref_primary_10_3389_fneur_2020_545377
crossref_primary_10_1177_13524585231151212
crossref_primary_10_1016_j_msard_2016_09_009
crossref_primary_10_1080_13854046_2016_1189597
crossref_primary_10_1016_j_ergon_2019_04_001
crossref_primary_10_1016_j_msard_2019_101458
crossref_primary_10_2196_30394
crossref_primary_10_1177_13524585251344794
crossref_primary_10_1177_2055217317748972
crossref_primary_10_1016_j_jns_2016_01_010
crossref_primary_10_1111_sjop_13054
crossref_primary_10_1177_10731911211045125
crossref_primary_10_1177_1352458516688955
crossref_primary_10_1016_j_msard_2016_06_011
crossref_primary_10_1177_1352458517707345
crossref_primary_10_1016_j_msard_2020_101932
crossref_primary_10_1038_s41746_021_00401_y
crossref_primary_10_1177_1352458514533229
crossref_primary_10_1177_13524585241227762
crossref_primary_10_1177_13524585241264476
crossref_primary_10_1080_10447318_2022_2050540
crossref_primary_10_1177_1352458520913439
crossref_primary_10_1016_S1474_4422_14_70264_9
crossref_primary_10_1177_1352458518820272
crossref_primary_10_1177_1352458520937385
crossref_primary_10_1007_s00415_013_7204_8
crossref_primary_10_1007_s10072_013_1544_0
crossref_primary_10_1016_j_ncl_2024_05_010
crossref_primary_10_7224_1537_2073_2018_108
crossref_primary_10_1002_hbm_25299
crossref_primary_10_1177_13524585211049397
crossref_primary_10_1177_20552076221117740
crossref_primary_10_3390_jcm12041615
crossref_primary_10_1016_j_jns_2016_01_040
crossref_primary_10_1177_1352458513480251
crossref_primary_10_1016_j_gaitpost_2018_09_020
crossref_primary_10_1016_j_jns_2018_10_004
crossref_primary_10_1136_bmjopen_2018_026622
crossref_primary_10_2196_18160
crossref_primary_10_1016_j_msard_2023_104709
crossref_primary_10_1016_j_jns_2017_09_030
crossref_primary_10_1097_YCT_0000000000000502
crossref_primary_10_1093_arclin_acv028
crossref_primary_10_1016_j_clineuro_2021_106805
crossref_primary_10_3233_NRE_151282
crossref_primary_10_3389_fneur_2022_995690
crossref_primary_10_1177_1352458515579443
crossref_primary_10_1177_2055217316657116
crossref_primary_10_1007_s40263_016_0319_6
crossref_primary_10_1007_s10072_017_2813_0
crossref_primary_10_1016_j_neurot_2025_e00581
crossref_primary_10_1080_13803395_2014_989818
crossref_primary_10_1007_s12311_021_01312_0
crossref_primary_10_1016_j_cct_2021_106331
crossref_primary_10_3389_fpsyg_2021_631535
crossref_primary_10_1016_j_msard_2022_103692
crossref_primary_10_1016_S1474_4422_20_30277_5
crossref_primary_10_1177_1352458517701588
crossref_primary_10_3389_fpsyg_2021_631536
crossref_primary_10_1016_j_msard_2023_104969
crossref_primary_10_1139_apnm_2024_0242
crossref_primary_10_1017_S1355617721000722
crossref_primary_10_2196_19598
crossref_primary_10_1016_j_msard_2017_08_006
crossref_primary_10_1016_j_msard_2015_08_003
crossref_primary_10_1080_23279095_2013_831866
crossref_primary_10_1177_1352458513496880
crossref_primary_10_1177_2055217321994853
crossref_primary_10_1177_1352458516633517
crossref_primary_10_1097_QAD_0000000000001842
crossref_primary_10_3390_brainsci11050637
crossref_primary_10_1136_jnnp_2024_335144
crossref_primary_10_1093_arclin_acy029
crossref_primary_10_1080_17518423_2022_2052374
Cites_doi 10.1038/nrneurol.2011.61
10.1212/WNL.53.1.139
10.1191/1352458502ms832oa
10.1017/S1355617705050782
10.1212/WNL.56.10.1324
10.1177/135245859900500409
10.1177/1352458509354552
10.1177/1352458509106615
10.1212/WNL.41.5.692
10.1177/1352458507075592
10.1177/1352458510378021
10.1176/jnp.13.1.70
10.1176/jnp.14.1.44
10.1177/1352458506070750
10.1191/135248506ms1227oa
10.1016/S1474-4422(08)70259-X
10.1136/jnnp.2004.045872
10.2466/pms.1977.44.2.367
10.1016/j.neuroimage.2007.04.017
10.1016/j.apmr.2007.11.059
10.1001/archneur.63.9.1301
10.1177/1051228404266267
10.1212/01.wnl.0000319694.14251.95
10.1212/01.WNL.0000129828.03714.90
10.1007/s00415-009-5074-x
10.1177/1352458508090923
10.1016/S0022-510X(02)00425-2
10.1212/01.WNL.0000072264.75989.B8
10.1136/jnnp.2008.148403
10.1001/archneur.61.2.226
10.1007/s00415-011-5975-3
10.3758/BF03193146
10.1017/S1355617709990750
10.1093/brain/122.7.1341
10.1177/1352458511404585
10.1212/WNL.0b013e318218107a
10.1017/S1355617706060723
10.1177/1352458508094398
10.1080/13854046.2010.511272
10.1212/01.WNL.0000142989.09633.5A
10.1016/j.jns.2004.12.009
10.1212/01.wnl.0000237641.33768.8d
10.1177/135245850100700409
ContentType Journal Article
Copyright The Author(s) 2012
2015 INIST-CNRS
SAGE Publications © Sep 2012
Copyright_xml – notice: The Author(s) 2012
– notice: 2015 INIST-CNRS
– notice: SAGE Publications © Sep 2012
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
H94
K9-
K9.
M0R
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1177/1352458511435717
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Proquest Central Journals
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Consumer Health Database (Alumni)
ProQuest Health & Medical Complete (Alumni)
Consumer Health Database
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest One Academic Middle East (New)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0970
EndPage 1325
ExternalDocumentID 2771936251
22277740
26359887
10_1177_1352458511435717
10.1177_1352458511435717
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations New York
GeographicLocations_xml – name: New York
GroupedDBID ---
-TM
.2E
.2F
.2G
.2J
.2N
01A
0R~
123
18M
1~K
29M
31R
31S
31U
31X
31Y
31Z
36B
39C
4.4
53G
54M
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADUE
AAEWN
AAGGD
AAGLT
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AANSI
AAPEO
AAQDB
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWC
ABAWP
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHFT
ABHKI
ABHQH
ABIDT
ABJIS
ABJNI
ABJZC
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADNON
ADRRZ
ADSTG
ADTBJ
ADUCT
ADUKL
ADVBO
ADYCS
ADZYD
ADZZY
AECGH
AECVZ
AEDTQ
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFQAA
AFUIA
AFVCE
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGQPQ
AGWFA
AGWNL
AHDMH
AHHFK
AHMBA
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
CAG
CBRKF
CCPQU
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EBS
EJD
EMOBN
F5P
FD6
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
K.J
K9-
M0R
M1P
N9A
O9-
P.B
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SASJQ
SAUOL
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
UKHRP
XJT
ZONMY
ZPPRI
ZRKOI
ZSSAH
0SE
AAEJI
AAPII
AAYXX
ABUAX
AFFHD
AJGYC
AJHME
AJVBE
CITATION
PJZUB
PPXIY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T5
7TK
7U9
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
ID FETCH-LOGICAL-c461t-5db62b08bd7ecde3b08bd674064d6b0d8a4eee09d644c2d3a4f56beba142bd2f3
IEDL.DBID 7X7
ISICitedReferencesCount 103
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000308138200057&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1352-4585
1477-0970
IngestDate Mon Sep 29 05:40:50 EDT 2025
Mon Oct 06 17:43:25 EDT 2025
Mon Jul 21 05:59:33 EDT 2025
Mon Jul 21 09:14:45 EDT 2025
Tue Nov 18 22:18:01 EST 2025
Sat Nov 29 08:13:23 EST 2025
Tue Jun 17 22:26:04 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Multiple sclerosis
symptomatic treatment
cognition
outcome measurement
Nervous system diseases
Prognosis
Cognition
Inflammatory disease
Treatment
Equivalence
Central nervous system disease
Clinical trial
Degenerative disease
Reliability
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c461t-5db62b08bd7ecde3b08bd674064d6b0d8a4eee09d644c2d3a4f56beba142bd2f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 22277740
PQID 1080740866
PQPubID 38324
PageCount 6
ParticipantIDs proquest_miscellaneous_1037655063
proquest_journals_1080740866
pubmed_primary_22277740
pascalfrancis_primary_26359887
crossref_citationtrail_10_1177_1352458511435717
crossref_primary_10_1177_1352458511435717
sage_journals_10_1177_1352458511435717
PublicationCentury 2000
PublicationDate 2012-09-01
PublicationDateYYYYMMDD 2012-09-01
PublicationDate_xml – month: 09
  year: 2012
  text: 2012-09-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: London
– name: England
PublicationTitle Multiple sclerosis
PublicationTitleAlternate Mult Scler
PublicationYear 2012
Publisher SAGE Publications
Sage Publications
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Sage Publications
– name: Sage Publications Ltd
References Parmenter, Weinstock-Guttman, Garg 2007; 13
Morrow, Kaushik, Zarevics 2009; 256
Faul, Erdfelder, Lang 2007; 39
Rovaris, Riccitelli, Judica 2008; 71
Huijbregts, Kalkers, de Sonneville 2004; 63
Strober, Englert, Munschauer 2009; 15
Boringa, Lazeron, Reuling 2001; 7
Benedict, Priore, Miller, Munschauer, Jacobs 2001; 13
Sumowski, Chiaravalloti, Erlanger 2011; 17
Benedict, Weinstock-Guttman, Fishman 2004; 61
Benedict, Bruce, Dwyer 2007; 13
Parmenter, Testa, Schretlen 2010; 16
Krupp, Christodoulou, Melville 2011; 76
Benedict, Bruce, Dwyer 2006; 63
Krupp, Christodoulou, Melville 2004; 63
Morrow, Jurgensen, Forrestal 2011; 258
Rudick, Cutter, Baier 2001; 56
Aupperle, Beatty, Shelton Fde, Gontkovsky 2002; 8
Benedict, Duquin, Jurgensen 2008
Benedict, Zivadinov 2011; 10
Kappos, Polman, Freedman 2006; 67
Benedict, Carone, Bakshi 2004; 14
Benedict, Zivadinov, Carone 2005; 26
Simon, Jacobs, Campion 1999; 53
Camp, Stevenson, Thompson 1999; 122
Nocentini, Giordano, Di Vincenzo 2006; 21
Benedict, Cookfair, Gavett 2006; 12
Chiaravalloti, DeLuca 2008; 7
Deloire, Salort, Bonnet 2005; 76
Benedict, Wahlig, Bakshi 2005
Tekok-Kilic, Benedict, Weinstock-Guttman 2007; 36
Gronwall 1977; 44
Benedict, Bakshi, Simon, Priore, Miller, Munschauer 2002; 14
Christodoulou, Krupp, Liang 2003; 60
Rao, Leo, Ellington 1991; 41
Brochet, Deloire, Bonnet 2008; 14
Goverover, Chiaravalloti, DeLuca 2008; 89
Nocentini, Pasqualetti, Bonavita 2006; 12
Morrow, O’Connor, Polman 2010; 16
Fischer, Rudick, Cutter 1999; 5
Drake, Weinstock-Guttman, Morrow 2010; 16
Benedict, Ramasamy, Munschauer 2009; 80
Bermel, Sharma, Tjoa 2003; 208
Benedict 2005; 11
Morrow, Drake, Zivadinov 2010; 24
bibr7-1352458511435717
bibr37-1352458511435717
bibr29-1352458511435717
bibr45-1352458511435717
bibr16-1352458511435717
Rao SM (bibr11-1352458511435717) 1991
bibr32-1352458511435717
bibr15-1352458511435717
bibr28-1352458511435717
bibr41-1352458511435717
bibr6-1352458511435717
bibr2-1352458511435717
bibr24-1352458511435717
bibr12-1352458511435717
bibr8-1352458511435717
bibr20-1352458511435717
bibr42-1352458511435717
bibr33-1352458511435717
bibr17-1352458511435717
bibr47-1352458511435717
bibr46-1352458511435717
bibr34-1352458511435717
bibr21-1352458511435717
bibr38-1352458511435717
bibr25-1352458511435717
bibr3-1352458511435717
Nocentini U (bibr18-1352458511435717) 2006; 21
bibr43-1352458511435717
bibr13-1352458511435717
Smith A (bibr10-1352458511435717) 1982
bibr48-1352458511435717
bibr4-1352458511435717
Benedict RHB (bibr30-1352458511435717) 2005; 26
bibr22-1352458511435717
bibr35-1352458511435717
bibr26-1352458511435717
bibr39-1352458511435717
bibr1-1352458511435717
bibr44-1352458511435717
bibr36-1352458511435717
bibr19-1352458511435717
bibr31-1352458511435717
bibr27-1352458511435717
bibr9-1352458511435717
bibr40-1352458511435717
bibr14-1352458511435717
bibr23-1352458511435717
bibr5-1352458511435717
References_xml – volume: 89
  start-page: 1514
  year: 2008
  end-page: 1521
  article-title: Self-generation to improve learning and memory of functional activities in persons with multiple sclerosis: meal preparation and managing finances
  publication-title: Arch Phy Med Rehabil
– volume: 71
  start-page: 1521
  year: 2008
  end-page: 1526
  article-title: Cognitive impairment and structural brain damage in benign multiple sclerosis
  publication-title: Neurology
– volume: 21
  start-page: 93
  year: 2006
  end-page: 96
  article-title: The Symbol Digit Modalities Test - Oral version: Italian normative data
  publication-title: Funct Neurol
– volume: 208
  start-page: 57
  year: 2003
  end-page: 65
  article-title: A semiautomated measure of whole-brain atrophy in multiple sclerosis
  publication-title: J Neurol Sci
– volume: 56
  start-page: 1324
  year: 2001
  end-page: 1330
  article-title: Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS
  publication-title: Neurology
– volume: 16
  start-page: 228
  year: 2010
  end-page: 237
  article-title: Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
  publication-title: Mult Scler
– volume: 80
  start-page: 201
  year: 2009
  end-page: 206
  article-title: Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 53
  start-page: 139
  year: 1999
  end-page: 148
  article-title: A longitudinal study of brain atrophy in relapsing multiple sclerosis
  publication-title: Neurology
– volume: 63
  start-page: 335
  year: 2004
  end-page: 339
  article-title: Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS
  publication-title: Neurology
– volume: 14
  start-page: 44
  year: 2002
  end-page: 51
  article-title: Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 41
  start-page: 692
  year: 1991
  end-page: 696
  article-title: Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning
  publication-title: Neurology
– volume: 63
  start-page: 1579
  year: 2004
  end-page: 1585
  article-title: Donepezil improves memory in multiple sclerosis in a randomized clinical trial
  publication-title: Neurology
– volume: 122
  start-page: 1341
  year: 1999
  end-page: 1348
  article-title: Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates
  publication-title: Brain
– volume: 44
  start-page: 367
  year: 1977
  end-page: 373
  article-title: Paced auditory serial addition task: A measure of recovery from concussion
  publication-title: Percept Motor Skills
– volume: 5
  start-page: 244
  year: 1999
  end-page: 250
  article-title: The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force
  publication-title: Mult Scler
– volume: 76
  start-page: 519
  year: 2005
  end-page: 526
  article-title: Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 256
  start-page: 1095
  year: 2009
  end-page: 1102
  article-title: The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial
  publication-title: J Neurol
– volume: 258
  start-page: 1603
  year: 2011
  end-page: 1608
  article-title: Effects of acute relapses on neuropsychological status in multiple sclerosis patients
  publication-title: J Neurol
– volume: 39
  start-page: 175
  year: 2007
  end-page: 191
  article-title: G*Power 3: A flexible statistical power analysis program for the social, behavioral and biomedical sciences
  publication-title: Behav Res Methods
– volume: 60
  start-page: 1793
  year: 2003
  end-page: 1798
  article-title: Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients
  publication-title: Neurology
– volume: 11
  start-page: 727
  year: 2005
  end-page: 736
  article-title: Effects of using same vs. alternate form memory tests in short-interval, repeated assessment in multiple sclerosis
  publication-title: J Int Neuropsychol Soc
– volume: 13
  start-page: 722
  year: 2007
  end-page: 730
  article-title: Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis
  publication-title: Mult Scler
– volume: 13
  start-page: 70
  year: 2001
  end-page: 76
  article-title: Personality disorder in multiple sclerosis correlates with cognitive impairment
  publication-title: J Neuropsychiatry Clin Neurosci
– volume: 63
  start-page: 1301
  year: 2006
  end-page: 1306
  article-title: Neocortical atrophy, third ventricular width, and cognitive dysfunciton in multiple sclerosis
  publication-title: Arch Neurol
– volume: 10
  start-page: 332
  year: 2011
  end-page: 342
  article-title: Risk factors for and management of cognitive dysfunction in multiple sclerosis
  publication-title: Nat Rev Neurol
– volume: 7
  start-page: 263
  year: 2001
  end-page: 267
  article-title: The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice
  publication-title: Mult Scler
– volume: 14
  start-page: 1242
  year: 2008
  end-page: 1249
  article-title: Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study
  publication-title: Mult Scler
– start-page: 940
  year: 2008
  end-page: 946
  article-title: Repeated Assessment of Neuropsychological Deficits in Multiple Sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
  publication-title: Mult Scler
– volume: 12
  start-page: 549
  year: 2006
  end-page: 558
  article-title: Validity of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)
  publication-title: J Int Neuropsychol Soc
– volume: 61
  start-page: 226
  year: 2004
  end-page: 230
  article-title: Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden
  publication-title: Arch Neurol
– volume: 26
  start-page: 1824
  year: 2005
  end-page: 1831
  article-title: Regional Lobar Atrophy Predicts Memory Impairment in Multiple Sclerosis
  publication-title: Am J Neuroradiol
– volume: 8
  start-page: 382
  year: 2002
  end-page: 389
  article-title: Three screening batteries to detect cognitive impairment in multiple sclerosis
  publication-title: Mult Scler
– volume: 12
  start-page: 77
  year: 2006
  end-page: 87
  article-title: Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
  publication-title: Mult Scler
– volume: 67
  start-page: 1242
  year: 2006
  end-page: 1249
  article-title: Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
  publication-title: Neurology
– volume: 16
  start-page: 6
  year: 2010
  end-page: 16
  article-title: The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
  publication-title: J Int Neuropsychol Soc
– volume: 16
  start-page: 228
  year: 2010
  end-page: 237
  article-title: Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASATwith the Symbol Digit Modalities Test
  publication-title: Mult Scler
– start-page: 29
  year: 2005
  end-page: 34
  article-title: Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change
  publication-title: J Neurol Sci
– volume: 36
  start-page: 1294
  year: 2007
  end-page: 1300
  article-title: Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis
  publication-title: NeuroImage
– volume: 16
  start-page: 1385
  year: 2010
  end-page: 1392
  article-title: Evaluation of the Symbol Digit Modalities Test (SDMT) and MS Neuropsychological Screening Questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
  publication-title: Mult Scler
– volume: 76
  start-page: 1500
  year: 2011
  end-page: 1507
  article-title: Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis
  publication-title: Neurology
– volume: 7
  start-page: 1139
  year: 2008
  end-page: 1151
  article-title: Cognitive impairment in multiple sclerosis
  publication-title: Lancet Neurol
– volume: 15
  start-page: 1077
  year: 2009
  end-page: 1084
  article-title: Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS
  publication-title: Mult Scler
– volume: 17
  start-page: 1141
  year: 2011
  end-page: 1145
  article-title: L-amphetamine improves memory in MS patients with objective memory impairment
  publication-title: Mult Scler
– volume: 14
  start-page: 36S
  issue: 3 Suppl
  year: 2004
  end-page: 45S
  article-title: Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis
  publication-title: J Neuroimaging
– volume: 24
  start-page: 1131
  year: 2010
  end-page: 1145
  article-title: Predicting loss of employment over three years in multiple sclerosis: Clinically meaningful cognitive decline
  publication-title: Clin Neuropsychol
– volume: 13
  start-page: 52
  year: 2007
  end-page: 57
  article-title: Screening for cognitive impairment in MS using the Symbol Digit Modalities Test
  publication-title: Mult Scler
– ident: bibr1-1352458511435717
  doi: 10.1038/nrneurol.2011.61
– ident: bibr14-1352458511435717
  doi: 10.1212/WNL.53.1.139
– ident: bibr9-1352458511435717
  doi: 10.1191/1352458502ms832oa
– ident: bibr36-1352458511435717
  doi: 10.1017/S1355617705050782
– ident: bibr7-1352458511435717
  doi: 10.1212/WNL.56.10.1324
– ident: bibr35-1352458511435717
  doi: 10.1177/135245859900500409
– ident: bibr38-1352458511435717
  doi: 10.1177/1352458509354552
– ident: bibr21-1352458511435717
  doi: 10.1177/1352458509106615
– ident: bibr41-1352458511435717
  doi: 10.1212/WNL.41.5.692
– ident: bibr29-1352458511435717
  doi: 10.1177/1352458507075592
– ident: bibr39-1352458511435717
  doi: 10.1177/1352458510378021
– ident: bibr13-1352458511435717
  doi: 10.1176/jnp.13.1.70
– ident: bibr12-1352458511435717
  doi: 10.1176/jnp.14.1.44
– ident: bibr22-1352458511435717
  doi: 10.1177/1352458506070750
– ident: bibr19-1352458511435717
  doi: 10.1191/135248506ms1227oa
– ident: bibr2-1352458511435717
  doi: 10.1016/S1474-4422(08)70259-X
– volume-title: A Manual for the Brief, Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis
  year: 1991
  ident: bibr11-1352458511435717
– ident: bibr16-1352458511435717
  doi: 10.1136/jnnp.2004.045872
– ident: bibr6-1352458511435717
  doi: 10.2466/pms.1977.44.2.367
– ident: bibr28-1352458511435717
  doi: 10.1016/j.neuroimage.2007.04.017
– ident: bibr4-1352458511435717
  doi: 10.1016/j.apmr.2007.11.059
– ident: bibr23-1352458511435717
  doi: 10.1001/archneur.63.9.1301
– ident: bibr31-1352458511435717
  doi: 10.1177/1051228404266267
– ident: bibr3-1352458511435717
  doi: 10.1212/01.wnl.0000319694.14251.95
– ident: bibr17-1352458511435717
  doi: 10.1212/01.WNL.0000129828.03714.90
– ident: bibr45-1352458511435717
  doi: 10.1007/s00415-009-5074-x
– volume: 26
  start-page: 1824
  year: 2005
  ident: bibr30-1352458511435717
  publication-title: Am J Neuroradiol
– volume: 21
  start-page: 93
  year: 2006
  ident: bibr18-1352458511435717
  publication-title: Funct Neurol
– ident: bibr37-1352458511435717
  doi: 10.1177/1352458508090923
– ident: bibr25-1352458511435717
  doi: 10.1016/S0022-510X(02)00425-2
– ident: bibr26-1352458511435717
  doi: 10.1212/01.WNL.0000072264.75989.B8
– ident: bibr34-1352458511435717
  doi: 10.1177/1352458509354552
– ident: bibr27-1352458511435717
  doi: 10.1136/jnnp.2008.148403
– ident: bibr32-1352458511435717
  doi: 10.1001/archneur.61.2.226
– ident: bibr47-1352458511435717
  doi: 10.1007/s00415-011-5975-3
– ident: bibr42-1352458511435717
  doi: 10.3758/BF03193146
– ident: bibr20-1352458511435717
  doi: 10.1017/S1355617709990750
– ident: bibr15-1352458511435717
  doi: 10.1093/brain/122.7.1341
– ident: bibr44-1352458511435717
  doi: 10.1177/1352458511404585
– ident: bibr46-1352458511435717
  doi: 10.1212/WNL.0b013e318218107a
– ident: bibr24-1352458511435717
  doi: 10.1017/S1355617706060723
– ident: bibr33-1352458511435717
  doi: 10.1177/1352458508094398
– ident: bibr48-1352458511435717
  doi: 10.1080/13854046.2010.511272
– ident: bibr43-1352458511435717
  doi: 10.1212/01.WNL.0000142989.09633.5A
– ident: bibr5-1352458511435717
  doi: 10.1016/j.jns.2004.12.009
– ident: bibr8-1352458511435717
  doi: 10.1212/01.wnl.0000237641.33768.8d
– ident: bibr40-1352458511435717
  doi: 10.1177/135245850100700409
– volume-title: Symbol digit modalities test: Manual
  year: 1982
  ident: bibr10-1352458511435717
SSID ssj0007735
Score 2.370833
Snippet Background: Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying...
Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies....
SourceID proquest
pubmed
pascalfrancis
crossref
sage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1320
SubjectTerms Adult
Analysis of Variance
Biological and medical sciences
Cognition
Cognition Disorders - diagnosis
Cognition Disorders - etiology
Cognition Disorders - psychology
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Female
Humans
Male
Medical sciences
Middle Aged
Multiple Sclerosis - complications
Multiple Sclerosis - diagnosis
Multiple Sclerosis - psychology
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Neurology
Neuropsychological Tests
New York
Predictive Value of Tests
Psychometrics
Reproducibility of Results
Research Design
Title Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials
URI https://journals.sagepub.com/doi/full/10.1177/1352458511435717
https://www.ncbi.nlm.nih.gov/pubmed/22277740
https://www.proquest.com/docview/1080740866
https://www.proquest.com/docview/1037655063
Volume 18
WOSCitedRecordID wos000308138200057&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Consumer Health Database
  customDbUrl:
  eissn: 1477-0970
  dateEnd: 20151231
  omitProxy: false
  ssIdentifier: ssj0007735
  issn: 1352-4585
  databaseCode: M0R
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1477-0970
  dateEnd: 20151231
  omitProxy: false
  ssIdentifier: ssj0007735
  issn: 1352-4585
  databaseCode: 7X7
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1477-0970
  dateEnd: 20151231
  omitProxy: false
  ssIdentifier: ssj0007735
  issn: 1352-4585
  databaseCode: BENPR
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7apJRC6fvhNl1UKIUezMq2LNm9lD4SetklpCnsbZEsKRhSexPvFvIP-rM7I3t3kxJy6UXYWJLH0kj6pBnPB_BOcC8SnctYeuFiobmKS1zZYm4p2Ijy2rgikE2o6bSYzcrD4cCtG9wq13NimKhtW9EZ-Zh84ZRAAC4_Lc5iYo0i6-pAoXEbdok2m_RczTYbLq5Ulm9Nk-MEwYYgMxhhBBUoyrZL0f2F7rBVfE9ncR3evOLrFZafg4f_K_gjeDAAT_a515THcMs1T-DuZDCtP4U_5JzcB-2-YLqxzJ2talRDGvms9SyY1RtEpoxgbkcpQ_DIflz8Mu0p-1af1Es2aS3hetx9s2OU8COrLzmshyJrB0bWoRTYLHXH1j9nssAg0j2Dnwf7x1-_xwNNQ1wJmSzj3BqZGl4Yq1xlXRYuJX6yFFYabgstnHO8tAi9qtRmWvhcGmd0IlJjU589h52mbdxLYJVMvPNlkpmiEjrLdWlt7rVziuNbhIlgvO6xeTXEMCcqjdN5MoQt_7ePI_iwKbHo43fckHd0RQk2BShgT4mzcQR76y6eD0O9m2_7N4K3m8c4SMnyohvXrigPzuO4F5RZBC96bdpWnqYKMTiP4D2p1-WKrxfz1c1SvIZ7COrS3g9uD3aW5yv3Bu5Uv5d1dz4KAySkxQh2v-xPD4_wbsKP_gIG6Bts
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1ba9RAFD7UKlYQ75dorSNowYewk2QykwgiYi0t7S6CK-xbnMnMlEBNts2usv_AX-Nv9Ewuu62UvvXBlyWwmckw880538l8OQfgNaOWBTLmPrfM-ExS4afo2XyqXbIRYaUySVNsQoxGyWSSflmDP_23ME5W2dvExlDrKnfvyAdOCycYEnD-YXriu6pR7nS1L6HRwuLALH5hyFa_39_B9X0Thrufx5_2_K6qgJ8zHsz8WCseKpooLUyuTdRccuyaM80V1YlkxhiaamQKeagjyWzMlVEyYKHSoY2w32twHe24cMGemCwDPCpEFK-OQgcBkhvmjt0cJxFNSbSV67s9lTWugm3LZ1zEb89pyxp3t3v3f5uoe3CnI9bkY7sT7sOaKR_AzWEnHXgIv534uk1KviCy1MSczAvcZs6ykcqSRjZQIvMmjsbX7pcgOSZfFz9UdUx2iqNiRoaVdnFLYWoyxhl5R4ozgvymSS_QJDWOApehqEn_8SlpKqTUj-DblczDY1gvq9I8BZLzwBqbBpFKciajWKZax1YaIyg-hSkPBj1CsrzL0e5KhRxnQZeW_V9MefB22WLa5ie55N6tc6BbNnAJiVL0Nh5s9pDKOlNWZys8efBq-TcaIXeyJEtTzd096Kcw1uWRB09a9K46D0OBMQb1YNvB-WzHFw_z2eWjeAkbe-PhYXa4Pzp4DreQwIat5m8T1menc_MCbuQ_Z0V9utVsTgLfrxrkfwH-eHhN
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reliability+and+equivalence+of+alternate+forms+for+the+Symbol+Digit+Modalities+Test%3A+implications+for+multiple+sclerosis+clinical+trials&rft.jtitle=Multiple+sclerosis&rft.au=Benedict%2C+Ralph+HB&rft.au=Smerbeck%2C+Audrey&rft.au=Parikh%2C+Rajavi&rft.au=Rodgers%2C+Jonathan&rft.date=2012-09-01&rft.pub=SAGE+Publications&rft.issn=1352-4585&rft.eissn=1477-0970&rft.volume=18&rft.issue=9&rft.spage=1320&rft.epage=1325&rft_id=info:doi/10.1177%2F1352458511435717&rft.externalDocID=10.1177_1352458511435717
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1352-4585&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1352-4585&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1352-4585&client=summon